List of chemotherapy regimens: Difference between revisions
Jump to navigation
Jump to search
| Line 59: | Line 59: | ||
| Newly diagnosed, aggressive [[non-Hodgkin lymphoma]] | | Newly diagnosed, aggressive [[non-Hodgkin lymphoma]] | ||
|- | |- | ||
| '''DHAP''' | | '''DHAP''' <ref name="pmid3334893">{{cite journal |author=Velasquez WS, Cabanillas F, Salvador P, ''et al.'' |title=Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) |journal=Blood |volume=71 |issue=1 |pages=117–22 |year=1988 |month=January |pmid=3334893 |doi= |url=}}</ref> | ||
| Dexamethasone, cytarabine (high-dose ARA-C), cisplatin | | Dexamethasone, cytarabine (high-dose ARA-C), cisplatin | ||
| Recurrent or refractory [[non-Hodgkin lymphoma]] | | Recurrent or refractory [[non-Hodgkin lymphoma]] | ||
| Line 75: | Line 75: | ||
| Relapsed or refractory [[non-Hodgkin lymphoma]] | | Relapsed or refractory [[non-Hodgkin lymphoma]] | ||
|- | |- | ||
| '''FN-D''' | | '''FN-D''' <ref name="pmid8648382">{{cite journal |author=McLaughlin P, Hagemeister FB, Romaguera JE, ''et al.'' |title=Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma |journal=J. Clin. Oncol. |volume=14 |issue=4 |pages=1262–8 |year=1996 |month=April |pmid=8648382 |doi= |url=}}</ref> | ||
| Fludarabine, mitoxantrone (Novantrone), dexamethasone | | Fludarabine, mitoxantrone (Novantrone), dexamethasone | ||
| Recurrent or refractory indolent [[non-Hodgkin lymphoma]] | | Recurrent or refractory indolent [[non-Hodgkin lymphoma]] | ||
| Line 83: | Line 83: | ||
| [[Colorectal cancer]] | | [[Colorectal cancer]] | ||
|- | |- | ||
| '''HYPER-CVAD''' | | '''HYPER-CVAD''' <ref name="pmid10561310">{{cite journal |author=Thomas DA, Cortes J, O'Brien S, ''et al.'' |title=Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia |journal=J. Clin. Oncol. |volume=17 |issue=8 |pages=2461–70 |year=1999 |month=August |pmid=10561310 |doi= |url=}}</ref> | ||
| Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone ([[Decadron]]) | | Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone ([[Decadron]]) | ||
| [[Burkitt's lymphoma]] | | [[Burkitt's lymphoma]] | ||
|- | |- | ||
| '''ICE''' | | '''ICE'' <ref name="pmid10577849">{{cite journal |author=Moskowitz CH, Bertino JR, Glassman JR, ''et al.'' |title=Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma |journal=J. Clin. Oncol. |volume=17 |issue=12 |pages=3776–85 |year=1999 |month=December |pmid=10577849 |doi= |url=}}</ref>' | ||
| Ifosfamide, carboplatin, etopiside | | Ifosfamide, carboplatin, etopiside | ||
| Relapsed or primary refractory [[non-Hodgkin lymphoma]] | | Relapsed or primary refractory [[non-Hodgkin lymphoma]] | ||
| Line 99: | Line 99: | ||
| [[Non-Hodgkin lymphoma]] | | [[Non-Hodgkin lymphoma]] | ||
|- | |- | ||
| '''MACOP-B''' | | '''MACOP-B'' '<ref name="pmid2580468">{{cite journal |author=Klimo P, Connors JM |title=MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma |journal=Ann. Intern. Med. |volume=102 |issue=5 |pages=596–602 |year=1985 |month=May |pmid=2580468 |doi= |url=}}</ref> | ||
| [[Methotrexate]], [[leucovorin]], [[doxorubicin]] (Adriamycin), [[cyclophosphamide]], [[vincristine]] (Oncovin), [[prednisone]], [[bleomycin]] | | [[Methotrexate]], [[leucovorin]], [[doxorubicin]] (Adriamycin), [[cyclophosphamide]], [[vincristine]] (Oncovin), [[prednisone]], [[bleomycin]] | ||
| Non-Hodgkin lymphoma | | Non-Hodgkin lymphoma | ||
Revision as of 13:15, 27 February 2010
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Chemotherapy regimens are often identified with acronyms, identifying the agents used in combination. Unfortunately, the letters used are not consistent across regimens, and in some cases (for example, "BEACOPP") the same letter is used to represent two different treatments. Because of this, there is not a naming standard for chemotherapy regimens, and this page merely represents commonly used conventions.
The term "Induction regimens" refers to a chemotherapy regimen which is used for the initial treatment of a disease.
- ↑ Wilson WH, Grossbard ML, Pittaluga S; et al. (2002). "Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy". Blood. 99 (8): 2685–93. PMID 11929754. Unknown parameter
|month=ignored (help) - ↑ Velasquez WS, Cabanillas F, Salvador P; et al. (1988). "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)". Blood. 71 (1): 117–22. PMID 3334893. Unknown parameter
|month=ignored (help) - ↑ McLaughlin P, Hagemeister FB, Romaguera JE; et al. (1996). "Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma". J. Clin. Oncol. 14 (4): 1262–8. PMID 8648382. Unknown parameter
|month=ignored (help) - ↑ Thomas DA, Cortes J, O'Brien S; et al. (1999). "Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia". J. Clin. Oncol. 17 (8): 2461–70. PMID 10561310. Unknown parameter
|month=ignored (help) - ↑ Moskowitz CH, Bertino JR, Glassman JR; et al. (1999). "Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma". J. Clin. Oncol. 17 (12): 3776–85. PMID 10577849. Unknown parameter
|month=ignored (help) - ↑ Klimo P, Connors JM (1985). "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma". Ann. Intern. Med. 102 (5): 596–602. PMID 2580468. Unknown parameter
|month=ignored (help)